361 Capital’s Alkermes ALKS Stock Holding History

361 Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,886	Closed	-$439K	–	319
2018 Q4	$439K	Buy	+14,886	New	+$549K	0.09%	278

Other funds holding ALKS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

361 Capital's ALKS Position: Q1 2019 in Review

361 Capital sold out of Alkermes (ALKS) in Q1 2019, closing a stake of 14,886 shares — an estimated $439K sold.

361 Capital first reported a position in ALKS in Q4 2018 and held it in 1 quarter. The position peaked at $439K in Q4 2018. 220 funds tracked by Wall St. Rank hold ALKS as of Q1 2019.

361 Capital reported no remaining Alkermes position as of Q1 2019 after selling out during the quarter.
361 Capital sold 14,886 Alkermes shares in Q1 2019, an estimated $439K.
361 Capital first reported a position in Alkermes in Q4 2018 and held it in 1 quarter.
361 Capital's Alkermes position peaked at $439K in Q4 2018.
220 funds tracked by Wall St. Rank held Alkermes as of Q1 2019.

Based on 361 Capital's 13F filing for Q1 2019, filed 7 May 2019.